Overheard: Drug of Choice Last year proved to be another good one for drug approvals. The U.S. regulator gave the nod to 35 drugs in total, up from 27 in 2013, although down slightly from 39 in 2012, according to Evercore ISI. In the 10 years before that, an average of only 23 drugs were approved each year.But approvals are one thing. Translating them into sales is another. One question is whether different companies are chasing the same market. Research and...
  